title: Dopaminergic Neurogenetics of Sleep Disorders in Reward Deficiency Syndrome (RDS).
abstract: It is well-known that sleep has a vital function especially as it relates to prevention of substance-related disorders as discussed in the DSM-V. We are cognizant that certain dopaminergic gene polymorphisms have been associated with various sleep disorders. The importance of"normal dopamine homeostasis"is tantamount for quality of life especially for the recovering addict. Since it is now know that sleep per se has been linked with metabolic clearance of neurotoxins in the brain, it is parsonomiuos to encourage continued research in sleep science, which should ultimately result in attenuation of sleep deprivation especially associated with substance related disorders.
authors: Department of Psychiatry, & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida, USA ; Department of Addiction Research & Therapy, Malibu Beach Recovery Center, Malibu Beach, California, USA ; Department of Nutrigenomics, IGENE, LLC, Austin, Texas, USA ; Dominion Diagnostics, LLC ., North Kingstown, Rhode Island, USA ; Department of Clinical Neurology, PATH Foundation NY., USA.
authors: Kenneth
authors: K
authors: Blum
authors: Department of Psychiatry and Anatomy & Neurobiology, Boston University School of Medicine and Boston VA Healthcare System, Boston, Massachusetts, USA.
authors: Marlene
authors: M
authors: Oscar-Berman
authors: Department of Neuroimaging and Psychiatry, University of Buffalo College of Medicine, Buffalo, New York., USA.
authors: Rajendra D
authors: RD
authors: Badgaiyan
authors: Department of Psychiatry, & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida, USA.
authors: Khurshid A
authors: KA
authors: Khurshid
authors: Department of Psychiatry, & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida, USA.
authors: Mark S
authors: MS
authors: Gold
keywords: Reward Deficiency Syndrome (RDS); dopaminergic system; metabolic clearance of neurotoxins; neurogenetics; sleep
references: Handb Clin Neurol. 2012;106:527-40
references: 22608642
references: Addict Behav. 2012 Nov;37(11):1205-10
references: 22742985
references: Subst Use Misuse. 2013 May;48(7):495-505
references: 23566203
references: Biol Psychiatry. 1998 Jul 15;44(2):121-8
references: 9646894
references: ScientificWorldJournal. 2007 Nov 02;7:223-30
references: 17982597
references: Psychiatry Res. 2010 Sep 30;179(2):238-40
references: 20493539
references: Drug Alcohol Depend. 2011 May 1;115(1-2):62-6
references: 21144676
references: Sleep Med. 2011 Dec;12 Suppl 2:S50-3
references: 22136900
references: Soc Sci Med. 2013 Feb;79:76-83
references: 23305724
references: Atten Defic Hyperact Disord. 2009 Dec;1(2):211-3
references: 21432583
references: Sleep Med Rev. 2012 Oct;16(5):431-43
references: 22055895
references: J Neurosci. 2014 Jan 8;34(2):566-73
references: 24403155
references: Psychiatry Investig. 2013 Dec;10(4):373-81
references: 24474986
references: Brain Res. 2012 Mar 9;1442:76-89
references: 22322149
references: J Affect Disord. 2008 Apr;107(1-3):181-6
references: 18031825
references: Prog Brain Res. 2011;193:51-61
references: 21854955
references: Eur Neuropsychopharmacol. 2012 Aug;22(8):537-45
references: 22209360
references: Psychosom Med. 2007 Jun;69(5):396-401
references: 17585061
references: Soc Sci Med. 2011 Apr;72(8):1367-73
references: 21458902
references: Br J Psychiatry. 2011 Nov;199(5):391-7
references: 21543823
references: Sleep. 2007 Jul;30(7):873-80
references: 17682658
references: Biol Psychiatry. 1998 Apr 15;43(8):601-7
references: 9564445
references: Genes Brain Behav. 2013 Mar;12(2):263-74
references: 23433184
references: Ugeskr Laeger. 2005 Oct 10;167(41):3893-4
references: 16221433
references: Genes Brain Behav. 2012 Feb;11(1):113-24
references: 21978078
references: Science. 2013 Oct 18;342(6156):373-7
references: 24136970
references: J Neurosci. 2009 Sep 2;29(35):10855-62
references: 19726643
references: Sleep Med Rev. 2003 Dec;7(6):523-39
references: 15018094
references: CNS Drugs. 2009;23 Suppl 2:15-26
references: 19708722
references: J Affect Disord. 2010 Feb;121(1-2):68-72
references: 19520435